Published in
Springer, International Journal of Clinical Oncology, 9(27), p. 1477-1486, 2022
DOI: 10.1007/s10147-022-02203-y
Links
Tools
Real-world outcomes and risk stratification in patients with metastatic castration-sensitive prostate cancer treated with upfront abiraterone acetate and docetaxel
Journal article published in 2022 by
Shintaro Narita 
,
Takahiro Kimura,
Shingo Hatakeyama,
Kenichi Hata,
Takafumi Yanagisawa,
Shinya Maita,
Shuji Chiba,
Hiromi Sato,
Soki Kashima ,
Atsushi Koizumi,
Ryohei Yamamoto,
Koichiro Takayama,
Katsumi Okane,
Toshiya Ishida,
Yohei Horikawa
and other authors.
,
Takahiro Kimura,
Shingo Hatakeyama,
Kenichi Hata,
Takafumi Yanagisawa,
Shinya Maita,
Shuji Chiba,
Hiromi Sato,
Soki Kashima ,
Atsushi Koizumi,
Ryohei Yamamoto,
Koichiro Takayama,
Katsumi Okane,
Toshiya Ishida,
Yohei Horikawa
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 